|
1
|
Cottin V, Wollin L, Fischer A, Quaresma M,
Stowasser S and Harari S: Fibrosing interstitial lung diseases:
knowns and unknowns. Eur Respir Rev. 28:1801002019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Podolanczuk AJ, Thomson CC, Remy-Jardin M,
Richeldi L, Martinez FJ, Kolb M and Raghu G: Idiopathic pulmonary
fibrosis: State of the art for 2023. Eur Respir J. 61:22009572023.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matson SM and Demoruelle MK: Connective
tissue disease-associated interstitial lung disease. Rheum Dis Clin
North Am. 50:423–438. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wan Q, Zhang X, Zhou D, Xie R, Cai Y,
Zhang K and Sun X: Inhaled nano-based therapeutics for pulmonary
fibrosis: Recent advances and future prospects. J
Nanobiotechnology. 21:2152023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Andersson-Sjöland A, de Alba CG, Nihlberg
K, Becerril C, Ramírez R, Pardo A, Westergren-Thorsson G and Selman
M: Fibrocytes are a potential source of lung fibroblasts in
idiopathic pulmonary fibrosis. Int J Biochem Cell Biol.
40:2129–2140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Al Oweidat KS, Abdulelah AA, Toubasi AA,
Abdulelah M, Alatteili NZ and Abdulelah ZA: The clinical efficacy
and safety of nintedanib in the treatment of interstitial lung
disease among patients with systemic sclerosis: Systematic review.
Can Respir J. 2025:16825462025.PubMed/NCBI
|
|
7
|
Qiu J, Söderlund-Venermo M and Young NS:
Human parvoviruses. Clin Microbiol Rev. 30:43–113. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arvia R, Stincarelli MA, Manaresi E,
Gallinella G and Zakrzewska K: Parvovirus B19 in rheumatic
diseases. Microorganisms. 12:17082024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tzang CC, Chi LY, Lee CY, Chang ZY, Luo
CA, Chen YH, Lin TA, Yu LC, Chen YR, Tzang BS and Hsu TC: Clinical
implications of human Parvovirus B19 infection on autoimmunity and
autoimmune diseases. Int Immunopharmacol. 147:1139602025.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Janner D, Bork J, Baum M and Chinnock R:
Severe pneumonia after heart transplantation as a result of human
parvovirus B19. J Heart Lung Transplant. 13:336–338.
1994.PubMed/NCBI
|
|
11
|
Bousvaros A, Sundel R, Thorne GM, McIntosh
K, Cohen M, Erdman DD, Perez-Atayde A, Finkel TH and Colin AA:
Parvovirus B19-associated interstitial lung disease, hepatitis, and
myositis. Pediatr Pulmonol. 26:365–369. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Atzeni F, Alciati A, Gozza F, Masala IF,
Siragusano C and Pipitone N: Interstitial lung disease in rheumatic
diseases: an update of the 2018 review. Expert Rev Clin Immunol.
21:209–226. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nikkari S, Mertsola J, Korvenranta H,
Vainionpää R and Toivanen P: Wegener's granulomatosis and
parvovirus B19 infection. Arthritis Rheum. 37:1707–1710. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Magro CM, Crowson AN, Dawood M and Nuovo
GJ: Parvoviral infection of endothelial cells and its possible role
in vasculitis and autoimmune diseases. J Rheumatol. 29:1227–1235.
2002.PubMed/NCBI
|
|
15
|
Magro CM, Nuovo G, Ferri C, Crowson AN,
Giuggioli D and Sebastiani M: Parvoviral infection of endothelial
cells and stromal fibroblasts: A possible pathogenetic role in
scleroderma. J Cutan Pathol. 31:43–50. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Magro CM, Allen J, Pope-Harman A, Waldman
WJ, Moh P, Rothrauff S and Ross P Jr: The role of microvascular
injury in the evolution of idiopathic pulmonary fibrosis. Am J Clin
Pathol. 119:556–567. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Chen X and Zhang Y: Interstitial
pneumonia with pulmonary parvovirus B19 infection. Med Clin (Barc).
159:e17–e18. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Magro CM, Wusirika R, Frambach GE, Nuovo
GJ, Ferri C and Ross P Jr: Autoimmune-like pulmonary disease in
association with parvovirus B19: A clinical, morphologic, and
molecular study of 12 cases. Appl Immunohistochem Mol Morphol.
14:208–216. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moffatt S, Tanaka N, Tada K, Nose M,
Nakamura M, Muraoka O, Hirano T and Sugamura K: A cytotoxic
nonstructural protein, NS1, of human parvovirus B19 induces
activation of interleukin-6 gene expression. J Virol. 70:8485–8491.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsu TC, Tzang BS, Huang CN, Lee YJ, Liu
GY, Chen MC and Tsay GJ: Increased expression and secretion of
interleukin-6 in human parvovirus B19 non-structural protein (NS1)
transfected COS-7 epithelial cells. Clin Exp Immunol. 144:152–157.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martinović Kaliterna D and Petrić M:
Biomarkers of skin and lung fibrosis in systemic sclerosis. Expert
Rev Clin Immunol. 15:1215–1223. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dsouza NN, Alampady V, Baby K, Maity S,
Byregowda BH and Nayak Y: Thalidomide interaction with inflammation
in idiopathic pulmonary fibrosis. Inflammopharmacology.
31:1167–1182. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arvia R, Margheri F, Stincarelli MA,
Laurenzana A, Fibbi G, Gallinella G, Ferri C, Del Rosso M and
Zakrzewska K: Parvovirus B19 activates in vitro normal human dermal
fibroblasts: A possible implication in skin fibrosis and systemic
sclerosis. Rheumatology (Oxford). 59:3526–3532. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jeganathan N and Sathananthan M:
Connective tissue disease-related interstitial lung disease:
Prevalence, patterns, predictors, prognosis, and treatment. Lung.
198:735–759. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smith RE, Strieter RM, Phan SH, Lukacs NW,
Huffnagle GB, Wilke CA, Burdick MD, Lincoln P, Evanoff H and Kunkel
SL: Production and function of murine macrophage inflammatory
protein-1 alpha in bleomycin-induced lung injury. J Immunol.
153:4704–4712. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maher TM, Wells AU and Laurent GJ:
Idiopathic pulmonary fibrosis: Multiple causes and multiple
mechanisms? Eur Respir J. 30:835–839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mor A, Segal Salto M, Katav A, Barashi N,
Edelshtein V, Manetti M, Levi Y, George J and Matucci-Cerinic M:
Blockade of CCL24 with a monoclonal antibody ameliorates
experimental dermal and pulmonary fibrosis. Ann Rheum Dis.
78:1260–1268. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chiang SR, Lin CY, Chen DY, Tsai HF, Lin
XC, Hsu TC and Tzang BS: The effects of human parvovirus VP1 unique
region in a mouse model of allergic asthma. PLoS One.
14:e02167992019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ishikawa Y, Iwata S, Hanami K, Nawata A,
Zhang M, Yamagata K, Hirata S, Sakata K, Todoroki Y, Nakano K, et
al: Relevance of interferon-gamma in pathogenesis of
life-threatening rapidly progressive interstitial lung disease in
patients with dermatomyositis. Arthritis Res Ther. 20:2402018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tzang CC, Lin WC, Huang ES, Kang YF, Cheng
YH, Tzang BS and Hsu TC: Interstitial lung disease biomarkers: A
systematic review and meta-analysis. Clin Chim Acta.
577:1204732025. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hübner RH, Gitter W, El Mokhtari NE,
Mathiak M, Both M, Bolte H, Freitag-Wolf S and Bewig B:
Standardized quantification of pulmonary fibrosis in histological
samples. Biotechniques. 44:507–511. 514–517. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mohammed SM, Al-Saedi HFS, Mohammed AQ,
Amir AA, Radi UK, Sattar R, Ahmad I, Ramadan MF, Alshahrani MY,
Balasim HM and Alawadi A: Mechanisms of bleomycin-induced lung
fibrosis: A review of therapeutic targets and approaches. Cell
Biochem Biophys. 82:1845–1870. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song C, He L, Zhang J, Ma H, Yuan X, Hu G,
Tao L, Zhang J and Meng J: Fluorofenidone attenuates pulmonary
inflammation and fibrosis via inhibiting the activation of NALP3
inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway. J Cell Mol Med.
20:2064–2077. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jegal Y, Kim DS, Shim TS, Lim CM, Do Lee
S, Koh Y, Kim WS, Kim WD, Lee JS, Travis WD, et al: Physiology is a
stronger predictor of survival than pathology in fibrotic
interstitial pneumonia. Am J Respir Crit Care Med. 171:639–644.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Artlett CM, Sassi-Gaha S, Hope JL,
Feghali-Bostwick CA and Katsikis PD: Mir-155 is overexpressed in
systemic sclerosis fibroblasts and is required for NLRP3
inflammasome-mediated collagen synthesis during fibrosis. Arthritis
Res Ther. 19:1442017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang WJ, Chen SJ, Zhou SC, Wu SZ and Wang
H: Inflammasomes and fibrosis. Front Immunol. 12:6431492021.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Colunga Biancatelli RML, Solopov PA and
Catravas JD: The Inflammasome NLR family pyrin domain-containing
protein 3 (NLRP3) as a novel therapeutic target for idiopathic
pulmonary fibrosis. Am J Pathol. 192:837–846. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hsu TC, Tsai CC, Chiu CC, Hsu JD and Tzang
BS: Exacerbating effects of human parvovirus B19 NS1 on liver
fibrosis in NZB/W F1 mice. PLoS One. 8:e683932013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Arvia R, Zakrzewska K, Giovannelli L,
Ristori S, Frediani E, Del Rosso M, Mocali A, Stincarelli MA,
Laurenzana A, Fibbi G and Margheri F: Parvovirus B19 induces
cellular senescence in human dermal fibroblasts: Putative role in
systemic sclerosis-associated fibrosis. Rheumatology (Oxford).
61:3864–3874. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang CL, Chen DY, Tzang CC, Lin JW, Tzang
BS and Hsu TC: Celastrol attenuates human parvovirus B19
NS1-induced NLRP3 inflammasome activation in macrophages. Mol Med
Rep. 28:1932023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Suzuki M, Ikari J, Anazawa R, Tanaka N,
Katsumata Y, Shimada A, Suzuki E and Tatsumi K: PAD4 deficiency
improves bleomycin-induced neutrophil extracellular traps and
fibrosis in mouse lung. Am J Respir Cell Mol Biol. 63:806–818.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen WC, Chen NJ, Chen HP, Yu WK, Su VY,
Chen H, Wu HH and Yang KY: Nintedanib reduces neutrophil chemotaxis
via activating GRK2 in bleomycin-induced pulmonary fibrosis. Int J
Mol Sci. 21:47352020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cheng IY, Liu CC, Lin JH, Hsu TW, Hsu JW,
Li AF, Ho WC, Hung SC and Hsu HS: Particulate matter increases the
severity of bleomycin-induced pulmonary fibrosis through
KC-mediated neutrophil chemotaxis. Int J Mol Sci. 21:2272019.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Garishah FM, Rother N, Riswari SF,
Alisjahbana B, Overheul GJ, van Rij RP, van der Ven A, van der Vlag
J and de Mast Q: Neutrophil extracellular traps in dengue are
mainly generated NOX-independently. Front Immunol. 12:6291672021.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
de Siqueira Santos R, Rochael NC, Mattos
TRF, Fallett E, Silva MF, Linhares-Lacerda L, de Oliveira LT, Cunha
MS, Mohana-Borges R, Gomes TA, et al: Peripheral nervous system is
injured by neutrophil extracellular traps (NETs) elicited by
nonstructural (NS) protein-1 from Zika virus. FASEB J.
37:e231262023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ghazipura M, Mammen MJ, Herman DD, Hon SM,
Bissell BD, Macrea M, Kheir F, Khor YH, Knight SL, Raghu G, et al:
Nintedanib in progressive pulmonary fibrosis: A systematic review
and meta-analysis. Ann Am Thorac Soc. 19:1040–1049. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Singh P, Thampi G, Gupta K, Gangte N,
Pattnaik B, Agrawal A and Kukreti R: Clinical efficacy and safety
evaluation of drug therapies for the treatment of progressive
fibrotic-interstitial lung diseases (PF-ILDs): A network
meta-analysis of randomized controlled trials. Expert Rev Clin
Immunol. 21:1135–1170. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Srivali N, De Giacomi F, Moua T and Ryu
JH: Perioperative antifibrotic therapy for patients with idiopathic
pulmonary fibrosis undergoing lung cancer surgery: A systematic
review and meta-analysis. Heart Lung. 74:266–275. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tang Z, Yang H, Liang X, Chen J, He Q, Zhu
D and Liu Y: Animal models for connective tissue disease-associated
interstitial lung disease: Current status and future directions.
Autoimmun Rev. 24:1039192025. View Article : Google Scholar : PubMed/NCBI
|
